TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Thu Feb 11

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 2:26 PM

NL

Article

TMFBiologyFool published an article 2:20 PM

Genomic Health, Inc. Eyes Profitability

With reimbursement in place, the test maker can get into the black this year.

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 1:56 PM

Rule Breakers article.

TMFBiologyFool published an update. 1:53 PM

Wed Feb 10

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 8:08 PM

NL

Article

TMFBiologyFool published an article 3:47 PM

Why NxStage Medical, Inc. Guided Lower Today

Despite a solid increase in revenue, investors in the dialysis company are disappointed with management's lackluster guidance.

NL

Article

TMFBiologyFool published an article 2:00 PM

Seattle Genetics, Inc. Grows Sales, Waits for Data

While Adcetris has had a good run, further sales expansion will require more data showing that it can help patients the drug isn't yet approved to treat.

Rule Breakers article.

TMFBiologyFool published an update. 1:57 PM

Tue Feb 9

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 3:07 PM

NL

Article

TMFBiologyFool published an article 1:18 PM

Why Cambrex Corporation Earned a Higher Share Price Today

A solid forecast for the year ahead pumped up the drugmaker.

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 2:41 AM

Rule Breakers article.

TMFBiologyFool published an update. 12:21 AM

Mon Feb 8

NL

Article

TMFBiologyFool published an article 7:40 PM

The One Question for Genomic Health, Inc.

As the cancer-test maker releases earnings, investors should be focused on profitability.

Rule Breakers article.

TMFBiologyFool published an update. 12:52 PM

NL

Article

TMFBiologyFool published an article 12:37 PM

Qiagen NV Is Prepping for Growth

With the decline in HPV test sales mostly behind it, the lab-test maker is looking for a stronger 2016 and beyond.

Fri Feb 5

NL

Article

TMFBiologyFool published an article 5:10 PM

Baxter International Inc. Rebuilding After Divorce

Modest revenue growth expected after the separation, but earnings look nice.

Thu Feb 4

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 4:53 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 4:33 PM

NL

Article

TMFBiologyFool published an article 4:15 PM

Novo Nordisk A/S Taps the Growth Brakes

The diabetes specialist expects to see slowing operating growth, but it has a good reason.

Stock Advisor article.

TMFBiologyFool published an update. 3:22 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 97.48
Player Rank 1886 out of 74884
Score 1683.34
Score Change Today -116.30
Accuracy 68.10%
Active Picks 73
Total Picks 215
Best Pick MNKD (+235.52)
Worst Pick INCY (-616.67)
Average Score per Pick 7.83
Charms Earned 10
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member
Board Posts 1134
Recs Received 1441
People who have rec'd these posts 530
Recs to Posts Ratio (last 30 days) 5.10
Threads Started 124
Threads Started Percentage 10.93 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 52.47 %
Show TMFBiologyFool’s 10 Latest Posts